Iovance Biotherapeutics, Inc. (IOVA)

CIK 1425205 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Iovance Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001104659-26-123030
Nov 5, 202610-Q0001193125-26-448809
Nov 5, 20268-K0001193125-26-450084
Oct 29, 20268-K0001104659-26-120261
Oct 5, 20268-K0001104659-26-113763
Oct 2, 202640001104659-26-113342
Oct 2, 202630001104659-26-113341
Sep 29, 20268-K0001104659-26-111583
Sep 10, 202640001104659-26-106748
Sep 10, 202640001104659-26-106750
Sep 10, 202640001104659-26-106752
Sep 3, 202640001104659-26-105100
Sep 3, 202640001104659-26-105099
Sep 3, 202640001104659-26-105101
Aug 12, 202640001104659-26-095040
Aug 10, 202640001104659-26-093482
Aug 7, 2026SCHEDULE 13G0000093751-26-000486
Aug 6, 20268-K0001104659-26-091619
Aug 6, 202610-Q0001104659-26-091716
Aug 6, 20268-K0001104659-26-092145
Jul 28, 2026SCHEDULE 13G/A0002012383-26-002600
Jul 2, 20268-K0001104659-26-080409
Jun 18, 202640001104659-26-075861
Jun 18, 202640001104659-26-075858
Jun 18, 202640001104659-26-075856